Authors: BEENTIKTAK AMM DEHAAS CJC DEGRAAF L BOUCHER CAB VERHOEF J BORLEFFS JCC NOTTET HSLM SCHUURMAN R

Citation: Amm. Beentiktak et al., IN-VITRO SELECTION OF HIV-1 VARIANTS RESISTANT TO NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS IN MONOCYTE-DERIVED MACROPHAGES, Journal of antimicrobial chemotherapy, 40(6), 1997, pp. 847-853

Authors: BEENTIKTAK AMM WILLIAMS I VREHEN HM RICHENS J ALDAM D VANLOON AM LOVEDAY C BOUCHER CAB WARD P WELLER IVD BORLEFFS JCC

Citation: Amm. Beentiktak et al., SAFETY, TOLERANCE, AND EFFICACY OF ATEVIRDINE IN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS, Antimicrobial agents and chemotherapy, 40(11), 1996, pp. 2664-2668

Authors: BEENTIKTAK AMM JOLY V SITBON G COLLIN G DEVOS M DEGRAAF L DEHAAN C BOUCHER C BRUMVEZINET F

Citation: Amm. Beentiktak et al., COMBINATION THERAPY WITH DELAVIRDINE MESYLATE AND AZT - VIROLOGY DATAFROM A EUROPEAN PHASE-II TRIAL, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 48-48

Authors: BEENTIKTAK AMM VREHEN HM SCHNEIDER MME VANDERFELTZ M BRANGER T WARD P COX SR HARRY JD BORLEFFS JCC

Citation: Amm. Beentiktak et al., SAFETY, TOLERANCE, AND PHARMACOKINETICS OF ATEVIRDINE MESYLATE (U-87201E) IN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 39(3), 1995, pp. 602-607